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Correspondence elucidated dermatophytic invasion of vellus hair in tinea corporis. [5] Finally, laboratory and clinical studies reporting development of resistance and cross resistance of dermatophytes to ergosterol synthesis inhibitors (ESI) specifically itraconazole, terbinafine, and amorolfine following repeated subcultures in sub-inhibitory drug concentrations (in vitro) and prolonged clinical therapy with azoles (in vivo) respectively, failed to show emergence of resistance to CPX. [3] The two most important factors plausibly contributing to the above phenomenon include: 1) unique ESI-independent antifungal mechanism of CPX that involves inhibition of the trivalent metal ion-dependent enzymes leading to accumulation of intracellular peroxides, and 2) irreversible binding to intracellular structures rescuing CPX from drug efflux mechanisms. [3] The potent antiinflammatory activity of CPX (equivalent to 2.5% hydrocortisone) is a boon, as cognizance of this fact can prevent prescription of steroid-based combination topicals that are often prescribed by clinicians to provide early relief to the patient; albeit at the cost of increasing the likelihood of therapeutic failure and the abuse of and dependence on such topicals by the patients. [3] 3. The role of agricultural fungicides contributing to primary azole resistance was mentioned, but the Indian scenario was missed out. Although European countries lead the globe in the usage of agricultural fungicides, trends in India are worrisome with a fungicide-to-total pesticide use ratio of 19% reported in 2007, resulting in incidence of azole-resistant filamentous fungi from soil samples in India increasing dramatically from 0% to 5% in [2002] [2003] [2004] and to 17%-20% just 5 years later, confirming the emergence and spread of azole-resistant fungi in the environment. [6] Despite unaltered overall consumption of pesticides in Indian agroindustry from 2012 to 2016, an estimated 34.2% increase occurred in use of fungicides [7] 4. The emergence of multi-triazole-resistant and multi-drug-resistant Aspergillus fumigatus, and other saprophytic molds and yeasts posing a real threat of untreatable invasive and systemic infections in immunocompromised individuals in India was missing, a vital aspect that deserved substantial discussion.
Although there are many other issues worth deliberation, the aforementioned are the most important. I strongly recommend that any future reviews/commentaries addressing this issue must ensure a more comprehensive approach with emphasis on data from the Indian subcontinent.
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Sir, We sincerely appreciate the interest of the author in our review article "Antifungal resistance in dermatology." [1] 1. Medical jargon is often described as the second language of healthcare professionals. [2] The authors agree that varied terminologies can add to the existing confusion. They thereby prefer to adhere to the existing nomenclature pending consensus Clinical resistance is defined as the failure to eradicate a fungal infection despite the administration of an antifungal agent with in vitro activity against the organism. Clinical resistance depends on various host and drug-related factors. [1] A knowledge of distinction between clinical and microbiological resistance is required for various causative factors and their therapeutic outcome. 2. Ciclopirox olamine is approved as a topical formulation for superficial mycoses. Studies have shown that itraconazole and terbinafine have a lower minimum inhibitory concentration (MIC) than ciclopirox against Trichophyton rubrum and Trichophyton mentagrophytes. [3] Susceptibility tests on Candida albicans revealed a lower MIC for itraconazole and ketoconazole when compared to ciclopirox [4] Antimicrobial drug resistance is an almost inevitable process that is universal in the microbial world. [1] Ciclopirox also induces change in expression of genes encoding multidrug resistance efflux pumps CDR1 and CDR2. [5] Considering the above facts and the present nature of dermatophytosis, excessive reliance on any single topical medication for therapeutic goals may be unwarranted. 3. The author highlighted the fungicide usage in agriculture and azole-resistant filamentous fungi in Indian settings. 4. The main focus of our article remained the mechanism of antifungal resistance in dermatology and broad therapeutic outlines. A comprehensive review of antifungal resistance was beyond the scope of the article.
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